ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
| Revenue (TTM) | $2.16B |
| Gross Profit (TTM) | $818.16M |
| EBITDA | $311.45M |
| Operating Margin | 5.73% |
| Return on Equity | 2.26% |
| Return on Assets | 1.68% |
| Revenue/Share (TTM) | $87.33 |
| Book Value | $84.50 |
| Price-to-Book | 1.68 |
| Price-to-Sales (TTM) | 1.65 |
| EV/Revenue | 2.13 |
| EV/EBITDA | 15.35 |
| Quarterly Earnings Growth (YoY) | -23.80% |
| Quarterly Revenue Growth (YoY) | -12.30% |
| Shares Outstanding | $24.99M |
| Float | $24.51M |
| % Insiders | 3.80% |
| % Institutions | 113.70% |
Volatility is currently contracting